In line with its ongoing commitment to providing Bahraini youth and with meaningful educational and developmental ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...

Beeline Medicines Corporation, a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people with autoimmune and ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially ...

Sean Moore joined the Twins in February of 2022 as the club’s first ever Vice President, Brand Partnerships. In his role, Moore oversees the development and implementation of strategies, plans and ...

Diranersen presentation will feature Phase 2 CELIA data in early Alzheimer's disease, including clinical, biomarker and safety results for Biogen's investigational tau-targeting ASO, following topline ...

FCAS is dead. After nine years and no prototype, Europe's flagship fighter program collapsed, leaving GCAP as the only active ...

Target expands its curated marketplace with brands that support its differentiated merchandising strategy, putting 'Tar-zhay' ...

Target built a generative AI system to improve marketing campaign forecasting by retrieving and ranking similar historical ...

The Dignity-Based Leadership Development Program for the 2025–2026 academic year will offer a range of programs designed to help current and emerging leaders strengthen their capacity to lead with ...

Target is laying off about 500 people in distribution centers and regional offices, according to a new report citing an internal company memo, which comes on the heels of Longtime CEO Brian Cornell ...